Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$6.86 - $8.79 $407,628 - $522,310
-59,421 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$6.31 - $8.4 $528,487 - $703,533
-83,754 Reduced 58.5%
59,421 $505,000
Q2 2021

Aug 10, 2021

SELL
$6.25 - $8.25 $78,856 - $104,090
-12,617 Reduced 8.1%
143,175 $996,000
Q1 2021

May 10, 2021

SELL
$4.95 - $7.7 $42,891 - $66,720
-8,665 Reduced 5.27%
155,792 $966,000
Q4 2020

Feb 11, 2021

SELL
$3.67 - $5.1 $9,931 - $13,800
-2,706 Reduced 1.62%
164,457 $837,000
Q3 2020

Nov 12, 2020

SELL
$4.33 - $6.05 $37,813 - $52,834
-8,733 Reduced 4.96%
167,163 $737,000
Q2 2020

Aug 12, 2020

SELL
$4.9 - $6.14 $332,425 - $416,549
-67,842 Reduced 27.83%
175,896 $967,000
Q1 2020

May 11, 2020

SELL
$4.63 - $10.62 $420,691 - $964,954
-90,862 Reduced 27.16%
243,738 $1.48 Million
Q4 2019

Feb 11, 2020

BUY
$8.7 - $9.79 $36,609 - $41,196
4,208 Added 1.27%
334,600 $3.06 Million
Q3 2019

Nov 12, 2019

BUY
$7.2 - $10.2 $83,664 - $118,523
11,620 Added 3.65%
330,392 $3.01 Million
Q2 2019

Aug 09, 2019

BUY
$9.5 - $14.5 $166,155 - $253,605
17,490 Added 5.81%
318,772 $3.22 Million
Q1 2019

May 10, 2019

BUY
$13.83 - $19.63 $703,864 - $999,049
50,894 Added 20.33%
301,282 $4.23 Million
Q4 2018

Feb 08, 2019

BUY
$14.15 - $18.99 $15,706 - $21,078
1,110 Added 0.45%
250,388 $3.97 Million
Q3 2018

Nov 09, 2018

SELL
$18.7 - $21.72 $607,076 - $705,118
-32,464 Reduced 11.52%
249,278 $4.69 Million
Q2 2018

Aug 08, 2018

BUY
$18.55 - $21.37 $9,646 - $11,112
520 Added 0.18%
281,742 $5.42 Million
Q1 2018

May 10, 2018

SELL
$19.52 - $22.64 $91,373 - $105,977
-4,681 Reduced 1.64%
281,222 $6.01 Million
Q4 2017

Feb 12, 2018

BUY
$16.63 - $21.24 $491,316 - $627,514
29,544 Added 11.52%
285,903 $5.88 Million
Q3 2017

Nov 09, 2017

BUY
$17.43 - $21.51 $4.47 Million - $5.51 Million
256,359
256,359 $4.73 Million

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $10.6M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Tieton Capital Management, LLC Portfolio

Follow Tieton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tieton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tieton Capital Management, LLC with notifications on news.